IP Library Granted Patent US 9,788,886
Granted Patent B2
US 9,788,886 · App. 15/272,007 · Granted Oct 17, 2017

Methods and devices to treat nasal airways

Inventors: Scott J. Wolf (Menlo Park, CA); Andrew Frazier (Sunnyvale, CA)
Assignee: AERIN MEDICAL INC.
A61B18/1442A61B18/02A61B18/1485A61B18/16A61F5/08A61B2018/00005A61B2018/00023A61B2018/00327A61B2018/00702A61B2018/00821A61B2018/00922A61B2018/0225A61B2018/143
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,788,886
App. No.
15/272,007
Granted
Oct 17, 2017
Kind
B2
Abstract

Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.

Claims (21)

1. A method of treating a patient's airway, the method comprising:

advancing a non-expandable, elongate treatment element of a treatment device through a nostril and into the patient's airway, wherein the elongate treatment element includes a tissue-contact surface having a shape;

contacting a pair of bipolar, radiofrequency electrodes protruding from the tissue-contact surface with tissue in the airway;

applying force against the tissue with the shape of the tissue-contact surface to at least temporarily deform the tissue to a desired shape;

delivering radiofrequency energy between the electrodes, to at least one of reshape, remodel, strengthen or change a property of the tissue; and

removing the treatment element from the airway.

2. A method as in claim 1 , further comprising forming an incision in mucosal tissue of the patient's airway, wherein the tissue to which the radiofrequency energy is delivered comprises submucosal tissue.

3. A method as in claim 2 , wherein the incision is formed using a cutting member on the treatment device.

4. A method as in claim 2 , wherein the submucosal tissue includes tissue selected from the group consisting of upper lateral cartilage, lower lateral cartilage, nasal septum within the nasal valve, nasal septum outside of the nasal valve, swell bodies located on a nasal septum, a septal turbinate, a high deviated nasal septum, a nasal scroll, a floor of the nasal cavity, a piriform area, and swell bodies on a floor of the nasal cavity.

5. A method as in claim 1 , wherein the shape of the tissue-contact surface comprises a shape selected from the group consisting of a flat shape, a convex shape, and a concave shape.

6. A method of treating a patient's airway, the method comprising:

advancing a treatment element of a treatment device through a nostril of a patient and into the patient's airway, the treatment device having a radiofrequency electrode needle extending from the treatment element;

inserting the radiofrequency electrode needle into tissue of the patient's airway to reach submucosal tissue to be treated;

delivering radiofrequency energy using the inserted radiofrequency electrode needle to at least one of reshape, remodel, strengthen or change a property of the submucosal tissue to be treated; and

removing the treatment element from the airway.

7. The method of claim 6 , wherein the radiofrequency electrode needle is a first radiofrequency electrode needle of a pair of bipolar radiofrequency needles, and wherein delivering radiofrequency energy using the inserted radiofrequency electrode needle comprises delivering radiofrequency energy between the pair of bipolar radiofrequency needles.

8. The method of claim 6 , wherein the radiofrequency electrode needle is a first radiofrequency electrode needle of multiple radiofrequency electrode needles extending from the treatment element, and wherein delivering radiofrequency energy using the inserted radiofrequency electrode needle comprises selectively delivering energy between one or more sets of the radiofrequency electrode needles or all of the radiofrequency electrode needles.

9. The method of claim 6 , further comprising applying a grounding pad to the patient, and wherein delivering radiofrequency energy using the inserted radiofrequency electrode needle comprises delivering radiofrequency energy between the radiofrequency electrode needle and the grounding pad.

10. The method of claim 6 , wherein the radiofrequency electrode needle comprises an insulator on part of the radiofrequency electrode needle, and wherein delivering radiofrequency energy using the inserted radiofrequency electrode needle comprises protecting non-target tissue from the delivered radiofrequency energy using the insulator.

11. The method of claim 6 , further comprising using a mold to shape, configure, or deflect tissue.

12. The method of claim 6 , wherein the submucosal tissue to be treated includes tissue selected from the group consisting of upper lateral cartilage, lower lateral cartilage, nasal septum within the nasal valve, nasal septum outside of the nasal valve, swell bodies located on a nasal septum, a septal turbinate, a high deviated nasal septum, a nasal scroll, a floor of the nasal cavity, a piriform area, and swell bodies on a floor of the nasal cavity.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2024
From: CRG SERVICING LLC
To: AERIN MEDICAL INC.
Reel/Frame 069654/0467 →
SECURITY INTEREST Recorded Dec 20, 2024
From: AERIN MEDICAL INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 069746/0508 →
SECURITY INTEREST Recorded May 13, 2019
From: AERIN MEDICAL INC.
To: CRG SERVICING LLC
Reel/Frame 049161/0043 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2017
From: WOLF, SCOTT J.; FRAZIER, ANDREW
To: AERIN MEDICAL INC.
Reel/Frame 043310/0606 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2017
From: WOLF, SCOTT J.; FRAZIER, ANDREW
To: AERIN MEDICAL, INC.
Reel/Frame 043310/0716 →
Continuity (6)
Continuation 14754087 · Jun 29, 2015
Continuation 14319087 · Jun 30, 2014
Continuation In Part 13495844 · Jun 13, 2012
Provisional Application 61603864 · Feb 27, 2012
Provisional Application 61496930 · Jun 14, 2011
Related Publication 20170007316A1 · Jan 12, 2017